mNavInteractive Video Navigation for Cervical Cancer Screening in African American Women
mNav Interactive Video + Navigator
+ Educational Video
Urogenital Diseases+10
+ Genital Diseases
+ Uterine Cervical Diseases
Screening Study
Summary
Study start date: June 24, 2025
Actual date on which the first participant was enrolled.This clinical trial focuses on improving cervical cancer screening rates among African American women who are overdue for screening. The study aims to determine if a new, interactive video-based navigation program, called mNav, can be more effective than a standard educational video alone. The program is designed to address specific concerns and barriers that may prevent women from getting screened. By testing this approach, researchers hope to find a better way to encourage timely cervical cancer screenings, ultimately reducing health disparities and catching potential issues earlier for better health outcomes. Participants in the study are randomly placed into one of two groups. One group receives a personalized interactive video experience with guidance from an in-person navigator, while the other group watches a standard educational video tailored for African American women. Participants will complete two phone surveys, one at the start and another six months later, to assess changes in knowledge, attitudes, and intentions regarding screening. Six months after the start of the study, researchers will review clinic records to see if participants have completed cervical cancer screening. This approach helps to evaluate if the interactive video and personal support increase the likelihood of screening.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.288 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Screening Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 21 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * Black or African American woman * Nonadherent to USPSTF cervical cancer screening guidelines (no Pap test in the past 3 years or no HPV test in the past 5 years) * Age 21 to 65 years old * Not currently pregnant * No history of hysterectomy * Access to a mobile phone capable of receiving text messages and watching video content Exclusion Criteria: \*None
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
ISA Associates
Arlington, United States